ABEO analyst estimates
Abeona Therapeutics (ABEO) analyst ratings, the average price target and its range, and every firm's latest call.
ABEO analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Sep 17, 2026 | Roth Capital | Abeona Therapeutics initiated with a Buy at Roth Capital | $17.00 |
| Aug 14, 2026 | Oppenheimer | Abeona Therapeutics price target lowered to $21 from $22 at Oppenheimer | $21.00 |
| Aug 14, 2026 | Industrial Alliance Securities | Abeona Therapeutics price target lowered to $15 from $20 at Alliance Global | $15.00 |
| Mar 17, 2026 | Stifel Nicolaus | Abeona Therapeutics (ABEO) PT Lowered to $17 at Stifel on Zevaskyn sales estimates | $17.00 |
| May 16, 2025 | Stifel Nicolaus | Abeona Therapeutics price target lowered to $20 from $21 at Stifel | $20.00 |
| Mar 5, 2025 | Oppenheimer | Abeona Therapeutics initiated with an Outperform at Oppenheimer | $16.00 |
| Nov 14, 2022 | Leerink Partners | SVB Leerink Maintains Market Perform on Abeona Therapeutics, Raises Price Target to $6 | $6.00 |
- 3 firms rate ABEO: 3 buy, 0 hold, 0 sell.
- The average price target is $17.67 from None analysts, from $15.00 to $21.00.
Updated 2026-11-09 19:47 UTC